GLENMARK PHARMACEUTICALS
Long
Updated

1112. NR7IB for intraday 1:1 Risk reward ratio

43
biased toward bullish
SL compulsory
Trade closed: target reached

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.